AZNCF News and Press, AstraZeneca Plc From 08/01/21

AstraZeneca PLC (AZN) Q2 2021 Earnings Conference Call July 29, 2021 6:45 AM ET Company Participants Pascal Soriot - Executive Director and Chief Executive Officer Dave Fredrickson - EVP, Oncology Business Unit Ruud Dobber - EVP, BioPharmaceuticals Business Unit Marc Dunoyer - Executive Direc...

Fisher’s 13F portfolio value increased from ~$142B to ~$159B in Q2 2021. The Vanguard Intermediate-Term Corporate Bond ETF stake was increased substantially this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~14% of the portfolio. F...

The following slide deck was published by AstraZeneca PLC in conjunction with their 2021 Q2 earnings call. For further details see: AstraZeneca PLC 2021 Q2 - Results - Earnings Call Presentation

Zoom uses its expensive stock to enter adjacent market with the acquisition of Five9 for $14.7 billion. Monmouth Real Estate Investment Corporation's board supports the pending merger of MNR with Equity Commonwealth after receiving a competing offer from Starwood. Salesforce compl...

Moderna and Novavax are leading Biotech companies who are expected to be major competitors in the COVID-19 vaccine market moving forward. While Moderna has a strong head start in the market in 2021, Novavax's impending entry is likely to offer stiff competition. Both companies als...

Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...

Healthcare, financials, and technology led the way in Q2. Energy, materials, industrials, and gold could have done better. With regards to Bitcoin and digital assets, I made a mistake. I made some adjustments for Q3 and expect to discuss more gains three months from now. ...

Insilico Medicine, a Hong Kong company devoted to using AI to speed up drug discovery and R&D, closed a $255 million Series C round led by Warburg Pincus. Jointech, a Hangzhou medical device company, has raised $62 million over the last 15 months to support its orthopedic surgery ...

AstraZeneca (OTCMKTS: AZNCF) and the European Union (EU) both claim to have won a legal battle in which the EU accused the pharmaceutical company of not producing enough vaccine doses at a satisfactory speed. The company had originally committed to ...

After years of brewing its medicine, Sesen is poised to gain FDA approval for Vicineum as a treatment for non-muscle-invasive bladder cancer. In the VISTA trial, Vicineum demonstrated robust efficacy which trumped all competing molecules. Epitomized as a run-up phenomenon, Sesen s...